Skip to main content
. 2012 Aug 28;107(7):1100–1106. doi: 10.1038/bjc.2012.357

Figure 3.

Figure 3

Frequency of percentage errors between individual AUC and target AUC using BSA dosing, dose banding, or fixed dose for doxorubicin, topotecan, and irinotecan (considering SN-38 concentrations).